PURPOSE: In a pivotal phase III trial, the addition of trastuzumab to chemotherapy significantly improved response rate, time to disease progression, and overall survival in women with HER2 overexpressing metastatic breast cancer. We conducted an extension study to this trial to obtain additional sa...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!